# An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

> **NCT00941707** · PHASE2 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 86 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** JNJ 38518168
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00941707
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Due to a single, unexpected serious event, the trial was stopped.
- **Last updated:** 2013-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941707, "An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00941707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*